TY  - JOUR
T1  - MOdeling cardiovascular disease prevention—reply
AU  - Hingorani AD, Psaty BM
Y1  - 2010/03/03
N1  - 10.1001/jama.2010.189
JO  - JAMA
SP  - 835
EP  - 835
VL  - 303
IS  - 9
N2  - 
Although many of the estimates needed to populate decision models are already available, there has been relatively little comparative work on the performance and cost-effectiveness of available screening tests and risk scores. Also, the preferences of populations that might be targeted for primary prevention have yet to be adequately evaluated. The wide cost differential between generic and proprietary statins also needs to be considered.

SN  - 0098-7484
M3  - doi: 10.1001/jama.2010.189
UR  - http://dx.doi.org/10.1001/jama.2010.189
ER  -